Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
NCT00245713 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2013-11-26
Summary
Effect of adjunctive levetiracetam on polysomnography in adults with partial-onset epilepsy receiving a classical antiepileptic drug
Conditions
- Epilepsy, Partial
Interventions
- DRUG
Sponsors & Collaborators
-
UCB Pharma
lead INDUSTRY
Principal Investigators
-
UCB Clinical Trial Call Center · UCB Pharma
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-03-31
- Primary Completion
- 2004-11-30
- Completion
- 2004-11-30
More Related Trials
-
Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures
NCT00610454 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures
NCT01407523 ·Status: COMPLETED ·Phase: PHASE2
-
A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
NCT00367432 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age
NCT03340064 ·Status: COMPLETED ·Phase: PHASE3
-
Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method
NCT00600509 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures
NCT00615615 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures
NCT00152516 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization
NCT01392768 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy
NCT00630630 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and Romania.
NCT00614549 ·Status: COMPLETED
-
A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy
NCT00361010 ·Status: COMPLETED ·Phase: NA
-
Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy
NCT00150735 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
NCT00362141 ·Status: UNKNOWN ·Phase: PHASE2
-
A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)
NCT01228747 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults
NCT00150774 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus
NCT01150331 ·Status: COMPLETED ·Phase: PHASE3
-
Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.
NCT00150813 ·Status: COMPLETED ·Phase: PHASE3
-
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
NCT06866691 ·Status: RECRUITING ·Phase: PHASE4
-
An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy
NCT01506882 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA)
NCT00393614 ·Status: UNKNOWN ·Phase: PHASE4
-
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
NCT00160615 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam for Benign Rolandic Epilepsy
NCT00181116 ·Status: COMPLETED ·Phase: PHASE4
-
Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?
NCT03054285 ·Status: UNKNOWN ·Phase: PHASE4
-
A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
NCT00247364 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures
NCT01063764 ·Status: COMPLETED ·Phase: PHASE3